Athenex, Inc. Announces Second Quarter 2019 Financial Results, Positive Phase III Results on Oral Paclitaxel plus Encequidar and Increased Product Sales Guidance

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach